Coronavirus: Private company rises to 'exceptional challenge' to double antigen testing

The government's early response to COVID-19 showed the 'frailty' in our testing capacity, according to a private laboratory working with the NHS. Source BioScience is one of a small number of private companies processing antigen tests for the government, letting NHS staff and patients know if they have COVID-19. The chief operating officer at Source BioScience, Russell Wheatcroft, said he hopes the UK can learn from the pandemic and that there will be more 'significant investments' in testing.